Interview with Dr. Faiz Ansari , General Manager, Lilly Indonesia
07.05.2013
Related Interviews
Interview: Haris Izmee – Director, GE Healthcare Indonesia
Haris Izmee, director at GE Healthcare Indonesia, explains the strong commitment of the company towards improving access, affordability and quality and highlights the company’s significant investments in internal capabilities and…
Interview: Evie Yulin – Country Director, Merck Biopharma Indonesia
Evie Yulin, biopharma country director at Merck Indonesia, speaks towards the meaning of innovation in emerging countries and how the company engages in innovation beyond products. Since 2012, Merck has been…
Interview: Marlia Hayati Goestam – President Director & Joey Romana…
Marlia Hayati and Joey Romana, President Director and Vice President Director at PT Darya-Varia Laboratoria, share insights about the company’s strong brand equity and pioneering manufacturing strategy. In 2016, the…
Mexico / India Ties Deepen; Lilly COVID Drugs Approved; Lithium Opportunities
The latest from Mexican pharma, including government talks with Indian authorities to provide low-cost medicines, a new distribution pilot program led by the military, the authorization of two Lilly monoclonal…
Saudi Arabia / Lilly Signs MoU for Insulin Manufacturing
Saudi Arabia has one of the highest rates of diabetes in the world – over 17 percent of the population are diabetic – making the supply of insulin products a…
China / Sinopharm Looks to mRNA Vaccines; Hong Kong Biotech Investment Continues to Boom; Another Big Manufacturing Investment for Lonza
The latest news from Chinese pharma and biotech, including news that state-owned Sinopharm is now developing its own mRNA vaccine; an update on Hong Kong’s biotech investment ecosystem three year…
Latest Report
